XTANDI for Hormone-refractory prostate cancer: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

There are 8 adverse event reports in the FDA FAERS database where XTANDI was used for Hormone-refractory prostate cancer.

Most Reported Side Effects for XTANDI

Side Effect	Reports	%	Deaths	Hosp.
Malignant neoplasm progression	235	16.9%	110	34
Death	234	16.8%	234	13
Fatigue	162	11.6%	19	18
Drug ineffective	158	11.3%	7	11
Prostatic specific antigen increased	94	6.8%	5	7
Nausea	69	5.0%	5	13
Asthenia	62	4.5%	5	13
Decreased appetite	56	4.0%	12	8
Dizziness	52	3.7%	2	6
Diarrhoea	51	3.7%	3	12
Back pain	41	2.9%	6	10
Malaise	41	2.9%	4	9
Arthralgia	36	2.6%	5	5
Investigation	31	2.2%	6	31
Dyspnoea	30	2.2%	2	13